For a patient with B12 deficiency on Mounjaro 7.5mg and maximum dose Metformin, with an HbA1c of 43, which medication should be reduced?
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2026
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901191091290112 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Monitoring vitamin B12 levels is important in patients on metformin, but the evidence does not indicate a need to reduce tirzepatide or metformin solely due to vitamin B12 deficiency with current glucose control. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18471867 |
| institution | Zenodo |
| language | |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | For a patient with B12 deficiency on Mounjaro 7.5mg and maximum dose Metformin, with an HbA1c of 43, which medication should be reduced? Tripdatabase B12 deficiency Mounjaro Metformin HbA1c medication management endocrinology pharmacology diabetes management vitamin deficiency drug interaction Monitoring vitamin B12 levels is important in patients on metformin, but the evidence does not indicate a need to reduce tirzepatide or metformin solely due to vitamin B12 deficiency with current glucose control. |
| title | For a patient with B12 deficiency on Mounjaro 7.5mg and maximum dose Metformin, with an HbA1c of 43, which medication should be reduced? |
| topic | B12 deficiency Mounjaro Metformin HbA1c medication management endocrinology pharmacology diabetes management vitamin deficiency drug interaction |
| url | https://doi.org/10.5281/zenodo.18471867 |